Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy |
|
https://doi.org/10.18632/oncotarget.27081
Stephen L. Luen,
Roberto Salgado,
and Sherene Loi
|
| 4612-4614 |
Age-dependent response to multimodal therapy for stage II-III rectal cancer
Age-dependent response to multimodal therapy for stage II-III rectal cancer |
|
https://doi.org/10.18632/oncotarget.27084
Daniel Delitto,
Tyler J. Loftus,
and Atif Iqbal
|
| 4615-4615 |
Oncologist uptake of comprehensive genomic profile guided targeted therapy
Oncologist uptake of comprehensive genomic profile guided targeted therapy |
|
https://doi.org/10.18632/oncotarget.27047
Mary K. Nesline,
Paul DePietro,
Grace K. Dy,
Amy Early,
Antonios Papanicolau-Sengos,
Jeffrey M. Conroy,
Felicia L. Lenzo,
Sean T. Glenn,
Hongbin Chen,
Anne Grand’Maison,
Patrick Boland,
Marc S. Ernstoff,
Igor Puzanov,
Stephen Edge,
Stacey Akers,
Mateusz Opyrchal,
Gurkamal Chatta,
Kunle Odunsi,
Peter Frederick,
Shashikant Lele,
Mark Gardner,
and Carl Morrison
|
| 4616-4629 |
Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt
Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt |
|
https://doi.org/10.18632/oncotarget.27050
Louise R. Dutton,
Owen P. Hoare,
Amy M.B. McCorry,
Keara L. Redmond,
Noor Eisa Adam,
Shannon Canamara,
Victoria Bingham,
Paul B. Mullan,
Mark Lawler,
Philip D. Dunne,
and Derek P. Brazil
|
| 4630-4639 |
Mutual suppression between BHLHE40/BHLHE41 and the MIR301B-MIR130B cluster is involved in epithelial-to-mesenchymal transition of endometrial cancer cells
Mutual suppression between BHLHE40/BHLHE41 and the MIR301B-MIR130B cluster is involved in epithelial-to-mesenchymal transition of endometrial cancer cells |
|
https://doi.org/10.18632/oncotarget.27061
Kazuo Asanoma,
Emiko Hori,
Sachiko Yoshida,
Hiroshi Yagi,
Ichiro Onoyama,
Keisuke Kodama,
Masafumi Yasunaga,
Tatsuhiro Ohgami,
Eisuke Kaneki,
Kaoru Okugawa,
Hideaki Yahata,
and Kiyoko Kato
|
| 4640-4654 |
Impact on survival of tobacco smoking for cases with oropharyngeal squamous cell carcinoma and known human papillomavirus and p16-status: a multicenter retrospective study
Impact on survival of tobacco smoking for cases with oropharyngeal squamous cell carcinoma and known human papillomavirus and p16-status: a multicenter retrospective study |
|
https://doi.org/10.18632/oncotarget.27079
Christian Grønhøj,
Jakob Schmidt Jensen,
Steffen Wagner,
Christian Dehlendorff,
Jeppe Friborg,
Elo Andersen,
Claus Wittekindt,
Nora Würdemann,
Shachi Jenny Sharma,
Stefan Gattenlöhner,
Jens Peter Klussmann,
and Christian von Buchwald
|
| 4655-4663 |
CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer
CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer |
|
https://doi.org/10.18632/oncotarget.27083
Elisabet Frick,
Thorkell Gudjonsson,
Jorunn Eyfjord,
Jon Jonasson,
Laufey Tryggvadóttir,
Olafur Stefansson,
and Stefan Sigurdsson
|
| 4664-4678 |
Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair
Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair |
|
https://doi.org/10.18632/oncotarget.27086
Hasan Mahmud,
Arja ter Elst,
Frank J.G. Scherpen,
Tiny Meeuwsen-de Boer,
Kim R. Kampen,
Valérie de Haas,
Victor Guryev,
Maikel M. Peppelenbosch,
Steven M. Kornblau,
and Eveline S.J.M. de Bont
|
| 4679-4690 |
Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response
Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response |
|
https://doi.org/10.18632/oncotarget.27087
Alessia Garufi,
Gianandrea Traversi,
Maria Saveria Gilardini Montani,
Valerio D’Orazi,
Giuseppa Pistritto,
Mara Cirone,
and Gabriella D’Orazi
|
| 4691-4702 |
Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma
Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.27095
Omkara Lakshmi Veeranki,
Zhimin Tong,
Rashmi Dokey,
Alicia Mejia,
Jianhu Zhang,
Yawei Qiao,
Pankaj Kumar Singh,
Riham Katkhuda,
Barbara Mino,
Ramesh Tailor,
Jaime Rodriguez Canales,
Roland Bassett,
Jaffer Ajani,
Ji Yuan Wu,
Scott Kopetz,
Mariela Blum,
Wayne Hofstetter,
Michael Tetzlaff,
Sunil Krishnan,
Steven H. Lin,
and Dipen Maru
|
| 4703-4718 |
Correction: Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130CAS/Src inhibition by eribulin
Correction: Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130CAS/Src inhibition by eribulin |
|
https://doi.org/10.18632/oncotarget.27100
Nicholas F. Dybdal-Hargreaves,
April L. Risinger,
and Susan L. Mooberry
|
| 4719-4720 |
